All Stories

  1. QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors

    Article • Letters in Drug Design & Discovery, January 2024, Bentham Science Publishers

    Professor Anil Kumar Saxena, Assistant Professor MOHIT KUMAR, Dr Sisir Nandi

  2. Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking

    Article • Letters in Drug Design & Discovery, May 2022, Bentham Science Publishers

    Dr Sisir Nandi, Assistant Professor MOHIT KUMAR, Professor Anil Kumar Saxena

  3. Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID-19

    Article • March 2022, Bentham Science Publishers

    Professor Anil Kumar Saxena, Dr Sisir Nandi

  4. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents

    Article • Current Drug Targets, November 2021, Bentham Science Publishers

    Harekrishna Roy, Dr Sisir Nandi, Professor Anil Kumar Saxena, Asha Gummadi

  5. Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment

    Article • Current Topics in Medicinal Chemistry, October 2021, Bentham Science Publishers

    Harekrishna Roy, BHABANI SHANKAR NAYAK, Dr Sisir Nandi, Professor Anil Kumar Saxena

  6. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors

    Article • Current Topics in Medicinal Chemistry, August 2021, Bentham Science Publishers

    Dr Sisir Nandi, Professor Anil Kumar Saxena

  7. The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking

    Article • Combinatorial Chemistry & High Throughput Screening, June 2021, Bentham Science Publishers

    Assistant Professor MOHIT KUMAR, Dr Sisir Nandi, Professor Anil Kumar Saxena

  8. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors

    Article • Current Topics in Medicinal Chemistry, March 2021, Bentham Science Publishers

    Professor Anil Kumar Saxena, Shome Bhunia

  9. QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis

    Article • SAR and QSAR in Environmental Research, September 2019, Taylor & Francis

    Dr Sisir Nandi, Professor Anil Kumar Saxena

  10. Identification of Therapeutically Active Molecules against Anthrax through Structure and Ligand based Drug Design

    Article • Current Topics in Medicinal Chemistry, January 2019, Bentham Science Publishers

    Dr Sisir Nandi, Professor Anil Kumar Saxena

  11. Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity

    Article • Current Topics in Medicinal Chemistry, January 2019, Bentham Science Publishers

    Amit Gupta, Professor Anil Kumar Saxena, Akansha Mishra , RAVI SONKAR

  12. Molecular modelling studies in explaining the higher GPVI antagonistic activity of the racemic 2-(4-methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide than its enantiomers

    Article • SAR and QSAR in Environmental Research, October 2017, Taylor & Francis

    Professor Anil Kumar Saxena, Shome Bhunia

  13. Pharmacophore Modeling, Docking and Molecular Dynamics Studies on Caspase-3 Activators Binding at β-Tubulin Site

    Article • Current Computer - Aided Drug Design, July 2015, Bentham Science Publishers

    Professor Anil Kumar Saxena

  14. Molecular Modelling Based Target Identification for Endo-Peroxides Class of Antimalarials

    Article • Combinatorial Chemistry & High Throughput Screening, February 2015, Bentham Science Publishers

    Professor Anil Kumar Saxena

  15. ChemInform Abstract: Reinvestigations into Synthesis of Allyldithiocarbamates and Their Intramolecular Cyclization: Synthesis and Antihyperglycemic Activity of 2-Thioxothiazolidine-4-alkanoates.

    Article • ChemInform, January 2015, Wiley

    Professor Anil Kumar Saxena

  16. Novel Glycoconjugate of 8-Fluoro Norfloxacin Derivatives as Gentamicin-resistantStaphylococcus aureusInhibitors: Synthesis and Molecular Modelling Studies

    Article • Chemical Biology & Drug Design, January 2015, Wiley

    Professor Anil Kumar Saxena, Dr Chandra Sourabh Azad

  17. Stereoconvergent synthesis of 1-deoxynojirimycin isomers by using the 3 component 4 centred Ugi reaction

    Article • Organic Chemistry Frontiers, January 2015, Royal Society of Chemistry

    Professor Anil Kumar Saxena, Dr Chandra Sourabh Azad

  18. Improved oral bioavailability of novel antithrombotic S002-333 via chitosan coated liposomes: a pharmacokinetic assessment

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor Anil Kumar Saxena

  19. Operative conversions of 3-carboxy-4-quinolones into 3-nitro-4-quinolones via ipso-nitration: potential antifilarial agents as inhibitors of Brugia malayi thymidylate kinase

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor Anil Kumar Saxena, Dr Chandra Sourabh Azad

  20. Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking

    Article • European Journal of Medicinal Chemistry, November 2014, Elsevier

    Professor Anil Kumar Saxena

  21. Pharmacokinetic and metabolism studies of rohitukine in rats by high performance liquid-chromatography with tandem mass spectrometry

    Article • Fitoterapia, September 2014, Elsevier

    Professor Anil Kumar Saxena

  22. ChemInform Abstract: Metal-Free, Mild, Nonepimerizing, Chemo- and Enantio- or Diastereoselective N-Alkylation of Amines by Alcohols via Oxidation/Imine-Iminium Formation/Reductive Amination: A Pragmatic Synthesis of Octahydropyrazinopyridoindoles and High

    Article • ChemInform, May 2014, Wiley

    Professor Anil Kumar Saxena

  23. Molecular cloning and characterization of Brugia malayi thymidylate kinase

    Article • Acta Tropica, May 2014, Elsevier

    Professor Anil Kumar Saxena

  24. ChemInform Abstract: (R/S)-BINOL-α-Phosphoryloxy Enecarbamate-Mediated and (R/S)-Titanium(IV) BINOLates-Catalyzed Enantioselective Intramolecular Heck/Aza-Diels-Alder Cycloaddition (IHADA): An Expedient Methodology.

    Article • ChemInform, March 2014, Wiley

    Professor Anil Kumar Saxena

  25. Purification and Physicochemical Characterization of a Trypsin Inhibitor from Cassia absus Linn

    Article • Protein and Peptide Letters, December 2013, Bentham Science Publishers

    Professor Anil Kumar Saxena

  26. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets

    Article • European Journal of Pharmacology, December 2013, Elsevier

    Professor Anil Kumar Saxena

  27. Erratum to: Antidyslipidemic and Antioxidant Effects of Novel Lupeol-Derived Chalcones

    Article • Lipids, September 2013, Wiley

    Professor Anil Kumar Saxena, Vijai Lakshmi

  28. (R/S)-BINOL-α-Phosphoryloxy Enecarbamate-Mediated and (R/S)-Titanium(IV) BINOLates-Catalyzed Enantioselective Intramolecular Heck/Aza-Diels-Alder Cycloaddition (IHADA): An Expedient Methodology

    Article • Advanced Synthesis & Catalysis, September 2013, Wiley

    Professor Anil Kumar Saxena

  29. In vitrometabolism of a novel antithrombotic compound, S002-333, and its enantiomers: quantitative cytochrome P450 phenotyping, metabolic profiling and enzyme kinetic studies

    Article • Xenobiotica, August 2013, Taylor & Francis

    Professor Anil Kumar Saxena

  30. Antidyslipidemic and Antioxidant Effects of Novel Lupeol-Derived Chalcones

    Article • Lipids, August 2013, Wiley

    Professor Anil Kumar Saxena, Vijai Lakshmi

  31. ChemInform Abstract: Room Temperature Palladium-Catalyzed Decarboxylative Acyl/Aroylation Using [Fe(III)(EDTA)(η2-O2)]3-as Oxidant at Biological pH.

    Article • ChemInform, August 2013, Wiley

    Professor Anil Kumar Saxena

  32. Identification and characterisation of small-molecule inhibitors of Rv3097c-encoded lipase (LipY) of Mycobacterium tuberculosis that selectively inhibit growth of bacilli in hypoxia

    Article • International Journal of Antimicrobial Agents, July 2013, Elsevier

    Professor Anil Kumar Saxena, Dr Laurent Kremer

  33. One pot conversion of carbohydrates alcohol into chloride via benzotriazole sulfonate

    Article • Tetrahedron, March 2013, Elsevier

    Professor Anil Kumar Saxena, Dr Chandra Sourabh Azad

  34. Room Temperature Palladium-Catalyzed Decarboxylative Acyl/Aroylation using [Fe(III)(EDTA)(η2-O2)]3−as Oxidant at Biological pH

    Article • Advanced Synthesis & Catalysis, February 2013, Wiley

    Professor Anil Kumar Saxena

  35. Identification of Novel Amino Acid Derived CCK-2R Antagonists As Potential Antiulcer Agent: Homology Modeling, Design, Synthesis, and Pharmacology

    Article • Journal of Chemical Information and Computer Sciences, January 2013, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  36. Identification of novel urea derivatives as PTP1B inhibitors: synthesis, biological evaluation and structure–activity relationships

    Article • MedChemComm, January 2013, Royal Society of Chemistry

    Professor Anil Kumar Saxena

  37. Identification and optimization of novel pyrimido-isoxazolidine and oxazine as selective hydride donors

    Article • Tetrahedron, December 2012, Elsevier

    Professor Anil Kumar Saxena

  38. Toward the Identification of a Reliable 3D QSAR Pharmacophore Model for the CCK2 Receptor Antagonism

    Article • Journal of Chemical Information and Computer Sciences, May 2012, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  39. Identification of Novel S-Adenosyl-l-Homocysteine Hydrolase Inhibitors through Homology-Model-Based Virtual Screening, Synthesis, and Biological Evaluation

    Article • Journal of Chemical Information and Computer Sciences, February 2012, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  40. Employing lactams for the unprecedented enantiopure synthesis of non-natural amino acid derivatives

    Article • Tetrahedron, January 2012, Elsevier

    Professor Anil Kumar Saxena

  41. Parikh–Doering oxidation–dehydration–Ugi cyclization cascade in the development of lactams from formidoalkanols (3>chain length>7)

    Article • Tetrahedron, January 2012, Elsevier

    Professor Anil Kumar Saxena

  42. Synthesis and 2D QSAR of O-sulphonated β-aminols derivatives as novel antifungal and antibacterial agents

    Article • Bioorganic & Medicinal Chemistry Letters, November 2011, Elsevier

    Professor Anil Kumar Saxena

  43. Structural Basis for the β-Adrenergic Receptor Subtype Selectivity of the Representative Agonists and Antagonists

    Article • Journal of Chemical Information and Computer Sciences, June 2011, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  44. Current trends in drug discovery research “CTDDR-2010”

    Article • Medicinal Chemistry Research, December 2010, Springer Science + Business Media

    Professor Anil Kumar Saxena

  45. Novel Carbamates as Orally Active Acetylcholinesterase Inhibitors Found to Improve Scopolamine-Induced Cognition Impairment: Pharmacophore-Based Virtual Screening, Synthesis, and Pharmacology †

    Article • Journal of Medicinal Chemistry, September 2010, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  46. Integration-mediated prediction enrichment of quantitative model for Hsp90 inhibitors as anti-cancer agents: 3D-QSAR study

    Article • Molecular Diversity, August 2010, Springer Science + Business Media

    Professor Anil Kumar Saxena

  47. Pharmacophore Modeling of Substituted 1,2,4-Trioxanes for Quantitative Prediction of their Antimalarial Activity †

    Article • Journal of Chemical Information and Computer Sciences, August 2010, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  48. 3D-QSAR CoMFA and CoMSIA studies on a set of diverse α1a-adrenergic receptor antagonists

    Article • Medicinal Chemistry Research, July 2010, Springer Science + Business Media

    Professor Anil Kumar Saxena

  49. ChemInform Abstract: Synthesis and SAR Studies of 1-Substituted-n-(4-alkoxycarbonylpiperidin-1-yl)alkanes as Potent Antiarrhythmic Agents.

    Article • ChemInform, June 2010, Wiley

    Professor Anil Kumar Saxena

  50. ChemInform Abstract: Microwave-Assisted Stereospecific Synthesis of (S)-3-Substituted 2,3,6,7,12,12a-Hexahydropyrazino[1′,2′:1,6]pyrido [3,4-b]indole-1,4-diones.

    Article • ChemInform, May 2010, Wiley

    Professor Anil Kumar Saxena

  51. ChemInform Abstract: Syntheses and QSAR Studies of 5-Imidazolinone Derivatives as Potential Antibacterial Agents.

    Article • ChemInform, May 2010, Wiley

    Professor Anil Kumar Saxena

  52. Synthesis of protein tyrosine phosphatase 1B inhibitors: Model validation and docking studies

    Article • Bioorganic & Medicinal Chemistry Letters, April 2009, Elsevier

    Professor Anil Kumar Saxena

  53. Substituted 1,2,3,4-tetrahydroquinolin-6-yloxypropanes as β3-adrenergic receptor agonists: Design, synthesis, biological evaluation and pharmacophore modeling

    Article • Bioorganic & Medicinal Chemistry, January 2009, Elsevier

    Professor Anil Kumar Saxena

  54. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis

    Article • Journal of Molecular Graphics and Modelling, September 2008, Elsevier

    Professor Anil Kumar Saxena

  55. ChemInform Abstract: Synthesis and QSAR Studies of Thiosemicarbazides, 1,2,4-Triazoles, 1,3,4-Thiadiazoles and 1,3,4-Oxadiazoles Derivatives as Potential Antibacterial Agents.

    Article • ChemInform, August 2008, Wiley

    Professor Anil Kumar Saxena

  56. Computer-Aided Discovery of Anti-Inflammatory Thiazolidinones with Dual Cyclooxygenase/Lipoxygenase Inhibition

    Article • Journal of Medicinal Chemistry, March 2008, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  57. 2D- QSAR studies on new stilbene derivatives of resveratrol as a new selective aryl hydrocarbon receptor

    Article • Medicinal Chemistry Research, January 2008, Springer Science + Business Media

    Professor Anil Kumar Saxena

  58. 2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells

    Article • Medicinal Chemistry Research, January 2008, Springer Science + Business Media

    Professor Anil Kumar Saxena

  59. QSAR analysis of PPAR-γ agonists as anti-diabetic agents

    Article • European Journal of Medicinal Chemistry, January 2008, Elsevier

    Professor Anil Kumar Saxena

  60. Computer-Aided Drug Design: Integration of Structure-Based and Ligand-Based Approaches in Drug Design

    Article • Current Computer - Aided Drug Design, June 2007, Bentham Science Publishers

    Professor Anil Kumar Saxena

  61. Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines

    Article • Bioorganic & Medicinal Chemistry Letters, March 2007, Elsevier

    Professor Anil Kumar Saxena

  62. 3D QSAR Studies on Protein Tyrosine Phosphatase 1B Inhibitors: Comparison of the Quality and Predictivity Among 3D QSAR Models Obtained from Different Conformer-Based Alignments.

    Article • ChemInform, February 2007, Wiley

    Professor Anil Kumar Saxena

  63. Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: Piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1)

    Article • Bioorganic & Medicinal Chemistry, December 2006, Elsevier

    Professor Anil Kumar Saxena

  64. QSAR Analysis of the Time- and Dose-Dependent Anti-Inflammatoryin vivo Activity of Substituted Imidazo[1,2-a]pyridines Using Artificial Neural Networks

    Article • QSAR & Combinatorial Science, July 2006, Wiley

    Professor Anil Kumar Saxena

  65. Evaluation of Binary QSAR Models Derived from LUDI and MOE Scoring Functions for Structure Based Virtual Screening

    Article • Journal of Chemical Information and Computer Sciences, January 2006, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  66. CoMFA and Docking Studies on Glycogen Phosphorylase a Inhibitors as Antidiabetic Agents.

    Article • ChemInform, April 2005, Wiley

    Professor Anil Kumar Saxena

  67. Characterization of β3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for β3 adrenergic receptor agonism

    Article • Journal of Computer-Aided Molecular Design, February 2005, Springer Science + Business Media

    Professor Anil Kumar Saxena

  68. CoMFA and Docking Studies on Glycogen Phosphorylase a Inhibitors as Antidiabetic Agents #

    Article • Journal of Chemical Information and Computer Sciences, January 2005, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  69. CURRENT TRENDS IN DRUG DISCOVERY RESEARCH

    Article • Medicinal Chemistry Research, October 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  70. SYNTHESIS, ANOREXIGENIC ACTIVITY AND QSAR OF SUBSTITUTED ARYLOXYPROPANOLAMINES

    Article • Medicinal Chemistry Research, October 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  71. QSAR AND MOLECULAR MODELING STUDIES IN IMIDAZOPYRIDINETHIAZOLIDINE-2,4-DIONES: PPARγ AGONISTS

    Article • Medicinal Chemistry Research, October 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  72. 3D-QSAR STUDIES ON SUBSTITUTED DIHYDROPYRIDINES FOR THEIR α1A-ADRENERGIC RECEPTOR BINDING AFFINITY

    Article • Medicinal Chemistry Research, October 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  73. CoMFA AND CoMSIA STUDIES ON A SET OF BENZYL PIPERAZINES, PIPERADINES, PYRAZINOPYRIDOINDOLES, PYRAZINOISOQUINOLINES AND SEMI RIGID ANALOGS OF DIPHENHYDRAMINE

    Article • Medicinal Chemistry Research, October 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  74. A CONVENIENT ROUTE FOR THE SYNTHESIS OF CIS-1-SUBSTITUTED 1,2,3,4,4a,5,11,11a-OCTAHYDRO-6H-PYRIDO[3,2-b]CARBAZOLES AND 4-SUBSTITUTED 1,2,3,4,4a,5,6,11c-OCTAHYDRO-7H-PYRIDO[2,3-c] CARBAZOLES AS POTENT DOPAMINE AGONISTS

    Article • Medicinal Chemistry Research, October 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  75. CURRENT TRENDS IN DRUG DISCOVERY RESEARCH

    Article • Medicinal Chemistry Research, July 2004, Springer Science + Business Media

    Professor Anil Kumar Saxena

  76. Development of CoMFA, advance CoMFA and CoMSIA models in pyrroloquinazolines as thrombin receptor antagonist

    Article • Bioorganic & Medicinal Chemistry, July 2004, Elsevier

    Professor Anil Kumar Saxena

  77. Pharmacophore identification and 3D-QSAR studies in N-(2-benzoyl phenyl)-l-tyrosines as PPARγ agonists

    Article • Bioorganic & Medicinal Chemistry, January 2004, Elsevier

    Professor Anil Kumar Saxena

  78. QSAR analysis of the time dependent hypotensive activity of 1-[3-(4-substituted phenylthio)propyl]-4-(3,4-substituted phenyl)piperazines using Artificial Neural Networks

    Article • QSAR & Combinatorial Science, December 2003, Wiley

    Professor Anil Kumar Saxena

  79. Development of 3D-QSAR models in cyclic ureidobenzenesulfonamides: human β3-Adrenergic receptor agonist

    Article • Bioorganic & Medicinal Chemistry Letters, August 2003, Elsevier

    Professor Anil Kumar Saxena

  80. QSAR studies in substituted 1,2,3,4,6,7,12,12a-octa-hydropyrazino[2′,1′:6,1]pyrido[3,4-b]indoles—a potent class of neuroleptics

    Article • Bioorganic & Medicinal Chemistry, May 2003, Elsevier

    Professor Anil Kumar Saxena

  81. Development of 3D-QSAR models for 5-Lipoxygenase antagonists: chalcones

    Article • Bioorganic & Medicinal Chemistry, December 2002, Elsevier

    Professor Anil Kumar Saxena

  82. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents

    Article • Bioorganic & Medicinal Chemistry, December 2002, Elsevier

    Professor Anil Kumar Saxena

  83. Preface

    Article • SAR and QSAR in Environmental Research, December 2001, Taylor & Francis

    Professor Anil Kumar Saxena

  84. Synthesis, molecular modeling and QSAR studies in chiral 2,3-disubstituted-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indoles as potential modulators of opioid antinociception

    Article • Bioorganic & Medicinal Chemistry, June 2001, Elsevier

    Professor Anil Kumar Saxena

  85. Microwave assisted stereospecific synthesis of (S)-3-substituted 2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-diones

    Article • Tetrahedron, May 2001, Elsevier

    Professor Anil Kumar Saxena

  86. 3-D QSAR studies of triazolinone based balanced AT1/AT2 receptor antagonists

    Article • Bioorganic & Medicinal Chemistry, February 2001, Elsevier

    Professor Anil Kumar Saxena

  87. Fourier transform infrared spectra and normal mode analysis of 1-[(3-methyl phenyl) piperazin-1-yl]-3-[thio(4-acetamido-phenyl]propane: a potent 5-HT2 and D2 receptor ligand

    Article • Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, June 2000, Elsevier

    Professor Anil Kumar Saxena

  88. Quantitative Structure-Activity and Structure-Toxicity Relationships of 4-Aminodiphenyl Sulphone Derivatives with Antiinflammatory Activity

    Article • Quantitative Structure-Activity Relationships, January 1999, Wiley

    Professor Anil Kumar Saxena

  89. Developments in anticonvulsants

    Article • January 1995, Springer Science + Business Media

    Professor Anil Kumar Saxena

  90. Reply to H. Kubinyi's Rebuttal

    Article • Quantitative Structure-Activity Relationships, January 1995, Wiley

    Professor Anil Kumar Saxena

  91. Physicochemical Significance of Topological Parameters, Connectivity Indices and Information Content. Part 1: Correlation Studies in the Sets with Aromatic and Aliphatic Substituents

    Article • Quantitative Structure-Activity Relationships, January 1995, Wiley

    Professor Anil Kumar Saxena

  92. Physicochemical Significance of Topological Parameters: Molecular Connectivity Index and Information Content: Part 2. Correlation Studies With Molar Refractivity and Lipophylicity

    Article • Quantitative Structure-Activity Relationships, January 1995, Wiley

    Professor Anil Kumar Saxena

  93. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques

    Article • January 1995, Springer Science + Business Media

    Professor Anil Kumar Saxena

  94. Application of QSAR and molecular modelling in designing 1-[4-arylpiperazin-1-yl]-3-thioarylpropanes: A new class of centrally acting hypotensive agents

    Article • January 1993, Springer Science + Business Media

    Professor Anil Kumar Saxena

  95. Developments in antihistamines (H1)

    Article • January 1992, Springer Science + Business Media

    Professor Anil Kumar Saxena

  96. Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of [.beta.-(aroylamino)ethyl]piperazines and -piperidines and [2-[(arylamino)carbonyl]ethyl]piperazines, -piperidines, -pyrazinopyridoindoles, and -pyrazinoisoq...

    Article • Journal of Medicinal Chemistry, November 1990, American Chemical Society (ACS)

    Professor Anil Kumar Saxena

  97. Pyrimidinones as biodynamic agents

    Article • January 1987, Springer Science + Business Media

    Professor Anil Kumar Saxena

  98. Advances in chemotherapy of malaria

    Article • January 1986, Springer Science + Business Media

    Professor Anil Kumar Saxena

  99. Syntheses and Biological Activities of 1,4-Disubstituted Piperidines

    Article • Archiv der Pharmazie, January 1984, Wiley

    Professor Anil Kumar Saxena

  100. A Convenient Method for the Synthesis of 2,6-Disubstituted 3-Aryl-4(3 H )-pyrimidones

    Article • Synthesis, January 1981, Thieme Publishing Group

    Professor Anil Kumar Saxena

  101. A Convenient Method for Indole N -Alkylation in Substituted Pyrazino[2′,1′:6,1]pyrido[3,4- b ]indoles

    Article • Synthesis, January 1981, Thieme Publishing Group

    Professor Anil Kumar Saxena

  102. Neuroleptic receptors: Stereoselectivity for neuroleptic enantiomers

    Article • European Journal of Pharmacology, June 1979, Elsevier

    Professor Anil Kumar Saxena

  103. Quantitative structure-activity relationships

    Article • January 1979, Springer Science + Business Media

    Professor Anil Kumar Saxena